Sabbe, M.
Schleich, F.
Janssens, P.
Louis, R.
Article History
Received: 22 March 2023
Accepted: 6 November 2023
First Online: 31 January 2024
Declarations
:
: Not applicable.
: Written informed consent was obtained from the patient for this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: R. Louis reports grants and personal fees from GSK, AZ, Chiesi, and Novartis and personal fees from Sanofi outside the submitted work. F. Schleich reports grants and personal fees for national board participation and presentations from GSK and AstraZeneca and personal fees for board participation and lectures from Chiesi outside the submitted work.